Showing 9401-9410 of 23018 results for "".
Protecting Heart Health in Metastatic Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/protecting-heart-health-in-metastatic-breast-cancer/39717/Metastatic breast cancer treatments have extended survival, but many therapies carry important cardiovascular risks that can impact long-term quality of life. As patients live longer, understanding the cardiac effects of these therapies is increasingly critical. Joining Ryan Quigley to discuss riskESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
https://reachmd.com/programs/project-oncology/esti-pulmonary-nodule-management-lung-cancer-screening/56339/Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
https://reachmd.com/programs/project-oncology/mutational-complexity-in-ros1-positive-mnsclc-insights-from-real-world-practice/36564/Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
https://reachmd.com/programs/neurofrontiers/program-name/36353/The Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
https://reachmd.com/programs/dermconsult/the-far-reaching-impacts-of-psoriasis-understanding-and-mitigating-risks/32452/Hear how psoriasis can impact a patient’s health beyond their skin and how to best support them to improve outcomes and minimize risks.7 Public Health Strategies to Combat Myopia
https://reachmd.com/programs/eye-on-ocular-health/7-public-health-strategies-to-combat-myopia/36279/Understanding Schizophrenia: Early Intervention and Prevention Strategies
https://reachmd.com/programs/frontlines-schizophrenia/understanding-schizophrenia-early-intervention-and-prevention-strategies/30032/Explore best practices for early detection, diagnosis, and treatment of schizophrenia.Spotting the Signs: Early Identification and Management of Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/spotting-the-signs-early-identification-and-management-of-schizophrenia/30031/Early signs of schizophrenia can be difficult to detect, but knowing the signs can help improve outcomes. Here’s what you should know.Key Highlights from SNMMI 2024
https://reachmd.com/programs/project-oncology/key-highlights-from-snmmi-2024/16501/What were some key highlights from SNMMI?Interchangeability and Biologics, Biosimilars, and Generics
https://reachmd.com/programs/clinicians-roundtable/interchangeability-and-biologics-biosimilars-and-generics/15987/With the ever-changing landscape of treatments, there are biosimilars for diabetes, inflammatory conditions, and cancers. Read more.